Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Cox

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Circulation. Arrhythmia and Electrophysiology|December 13, 2024
Performance of ARVC Risk Calculators in (Likely) Pathogenic Plakophilin-2 Variant Carriers Without Definite ARVC DiagnosisSteven A Muller, Babken Asatryan, Brittney Murray, et al.
Circulation. Arrhythmia and Electrophysiology|October 22, 2009
New ECG criteria in arrhythmogenic right ventricular dysplasia/cardiomyopathyMoniek G P J Cox, Jasper J van der Smagt, Arthur A M Wilde, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 9, 2011
Recurrent and founder mutations in the Netherlands : Plakophilin-2 p.Arg79X mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasiaP A van der Zwaag, M G P J Cox, C van der Werf, et al.
Circulation. Arrhythmia and Electrophysiology|March 11, 2010
Arrhythmogenic right ventricular dysplasia/cardiomyopathy diagnostic task force criteria: impact of new task force criteriaMoniek G P J Cox, Jasper J van der Smagt, Maartje Noorman, et al.
Journal of the American College of Cardiology|June 4, 2011
Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noiseJamie D Kapplinger, Andrew P Landstrom, Benjamin A Salisbury, et al.
Circulation|June 17, 2025
Family Screening in Relatives at Risk for Plakophilin-2-Associated Arrhythmogenic Right Ventricular CardiomyopathySteven A Muller, Babken Asatryan, Alessio Gasperetti, et al.
International Journal of Cardiology|April 13, 2025
Additional genetic variants in cardiomyopathy patients with the pathogenic PLN p.(Arg14del) founder variantE van Drie, J D H Jongbloed, E Hoorntje, et al.
Circulation|February 23, 2010
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteriaFrank I Marcus, William J McKenna, Duane Sherrill, et al.
European Heart Journal|February 23, 2010
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force CriteriaFrank I Marcus, William J McKenna, Duane Sherrill, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 1, 2024
Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark studyMyrthe Y C van der Heide, Tom E Verstraelen, Freyja H M van Lint, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Circulation. Arrhythmia and Electrophysiology|December 13, 2024
Performance of ARVC Risk Calculators in (Likely) Pathogenic Plakophilin-2 Variant Carriers Without Definite ARVC DiagnosisSteven A Muller, Babken Asatryan, Brittney Murray, et al.
Circulation. Arrhythmia and Electrophysiology|October 22, 2009
New ECG criteria in arrhythmogenic right ventricular dysplasia/cardiomyopathyMoniek G P J Cox, Jasper J van der Smagt, Arthur A M Wilde, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 9, 2011
Recurrent and founder mutations in the Netherlands : Plakophilin-2 p.Arg79X mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasiaP A van der Zwaag, M G P J Cox, C van der Werf, et al.
Circulation. Arrhythmia and Electrophysiology|March 11, 2010
Arrhythmogenic right ventricular dysplasia/cardiomyopathy diagnostic task force criteria: impact of new task force criteriaMoniek G P J Cox, Jasper J van der Smagt, Maartje Noorman, et al.
Journal of the American College of Cardiology|June 4, 2011
Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noiseJamie D Kapplinger, Andrew P Landstrom, Benjamin A Salisbury, et al.
Circulation|June 17, 2025
Family Screening in Relatives at Risk for Plakophilin-2-Associated Arrhythmogenic Right Ventricular CardiomyopathySteven A Muller, Babken Asatryan, Alessio Gasperetti, et al.
International Journal of Cardiology|April 13, 2025
Additional genetic variants in cardiomyopathy patients with the pathogenic PLN p.(Arg14del) founder variantE van Drie, J D H Jongbloed, E Hoorntje, et al.
Circulation|February 23, 2010
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteriaFrank I Marcus, William J McKenna, Duane Sherrill, et al.
European Heart Journal|February 23, 2010
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force CriteriaFrank I Marcus, William J McKenna, Duane Sherrill, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 1, 2024
Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark studyMyrthe Y C van der Heide, Tom E Verstraelen, Freyja H M van Lint, et al.
Pageof 14